future of glp 1 GLP-1R agonists: Full hope, use with caution Pharmacists Can Help Shape the

Each increment in BMI of 5 kg/m 2 greater than 22,525,0 kg/m 2 corresponds to a rise in overall mortality of 30% (3), in obese people the major death cause in CVD, followed by T2D (4)

This trend underscores the growing market potential for weight management and gut health dietary supplements , providing supplement distributors with opportunities to expand their portfolios in a high-demand, flexible category

Better energy, mood, and control over hunger

For people with inflammatory arthritis (e.g, Rheumatoid arthritis, Psoriatic Arthritis, Lupus), this risk is even higher because they experience more heart disease complications than the general population

HUBERMAN: I do read all the comments

Yes, over-the-counter antacids, H2 blockers like famotidine, or proton pump inhibitors (PPIs) can be used to manage heartburn on GLP-1 therapy